Display options
Share it on

Springerplus. 2015 Dec 08;4:760. doi: 10.1186/s40064-015-1546-x. eCollection 2015.

Effect of specimen type on free immunoglobulin light chains analysis on the Roche Diagnostics cobas 8000 analyzer.

SpringerPlus

Louis S Nelson, Bryan Steussy, Cory S Morris, Matthew D Krasowski

Affiliations

  1. Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242 USA.

PMID: 26682113 PMCID: PMC4671985 DOI: 10.1186/s40064-015-1546-x

Abstract

The measurement of free immunoglobulin light chains is typically performed on serum; however, the use of alternative specimen types has potential benefits. Using the Freelite™ kappa and lambda free light chains assay on a Roche Diagnostics cobas 8000 c502 analyzer, we compared three specimen types (serum, EDTA-plasma and lithium heparin plasma separator gel-plasma) on 100 patients. Using Deming regression and eliminating outliers (limiting data to light chain concentrations below 400 mg/L), the three specimen types showed comparable results for kappa light chain concentration, lambda light chain concentration, and kappa/lambda ratio with slopes close to 1.0 and y-intercepts close to zero. EDTA-plasma showed slightly more positive bias relative to serum than lithium heparin. Analysis using EDTA-plasma and lithium heparin plasma showed comparable linearity, precision, and temperature stability. A single sample showing hook effect (not in the comparison set) gave comparable results using either plasma specimen type. For the Freelite™ kappa and lambda free light chains assay, both EDTA-plasma or lithium heparin-plasma can serve as acceptable substitutes for serum, at least for the Roche cobas 8000 analyzer.

Keywords: Immunoglobulin light chains; Laboratory automation; Nephelometry; Plasma; Serum

References

  1. Am J Clin Pathol. 2013 Dec;140(6):890-7 - PubMed
  2. Leukemia. 2009 Feb;23(2):215-24 - PubMed
  3. BMC Med Inform Decis Mak. 2015 Feb 22;15:11 - PubMed
  4. Lancet. 2010 May 15;375(9727):1721-8 - PubMed
  5. Clin Chim Acta. 2015 Apr 15;444:297-302 - PubMed
  6. Blood. 2011 May 5;117(18):4701-5 - PubMed
  7. BMC Clin Pathol. 2015 Jun 07;15:11 - PubMed
  8. Biomed Res Int. 2014;2014:647238 - PubMed
  9. Br J Haematol. 2003 Jul;122(1):78-84 - PubMed
  10. J Clin Lab Anal. 2014 May;28(3):229-36 - PubMed
  11. Leukemia. 2008 Oct;22(10):1933-7 - PubMed
  12. Clin Chem. 2001 Apr;47(4):673-80 - PubMed
  13. Clin Biochem Rev. 2009 Aug;30(3):131-40 - PubMed
  14. Clin Chem Lab Med. 2010 Oct;48(10):1419-22 - PubMed
  15. J Pathol Inform. 2014 Mar 28;5(1):13 - PubMed
  16. Clin Biochem. 2013 May;46(7-8):691-3 - PubMed
  17. Clin Chem Lab Med. 2011 Aug;49(8):1323-32 - PubMed
  18. Clin Chem. 2003 Aug;49(8):1252-7 - PubMed
  19. Ther Adv Hematol. 2013 Feb;4(1):37-41 - PubMed
  20. Ann Clin Biochem. 2012 Sep;49(Pt 5):450-5 - PubMed
  21. Clin Chem Lab Med. 2010;48(1):73-9 - PubMed
  22. Clin Chem Lab Med. 2011 Nov 23;50(3):489-95 - PubMed
  23. Intern Med J. 2007 Jul;37(7):456-63 - PubMed
  24. Clin Chem. 2005 May;51(5):878-81 - PubMed
  25. Eur J Haematol. 2012 Dec;89(6):458-68 - PubMed

Publication Types